493 related articles for article (PubMed ID: 32213613)
1. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
Liu X; Cohen JI
J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
[TBL] [Abstract][Full Text] [Related]
3. Suppression of JAK-STAT Signaling by Epstein-Barr Virus Tegument Protein BGLF2 through Recruitment of SHP1 Phosphatase and Promotion of STAT2 Degradation.
Jangra S; Bharti A; Lui WY; Chaudhary V; Botelho MG; Yuen KS; Jin DY
J Virol; 2021 Sep; 95(20):e0102721. PubMed ID: 34319780
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus tegument protein BGLF2 inhibits NF-κB activity by preventing p65 Ser536 phosphorylation.
Chen T; Wang Y; Xu Z; Zou X; Wang P; Ou X; Li Y; Peng T; Chen D; Li M; Cai M
FASEB J; 2019 Sep; 33(9):10563-10576. PubMed ID: 31337264
[TBL] [Abstract][Full Text] [Related]
5. BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon
Konishi N; Narita Y; Hijioka F; Masud HMAA; Sato Y; Kimura H; Murata T
mSphere; 2018 Apr; 3(2):. PubMed ID: 29695622
[TBL] [Abstract][Full Text] [Related]
6. Protein inhibitor of activated STAT1 (PIAS1) inhibits IRF8 activation of Epstein-Barr virus lytic gene expression.
Zhang K; Lv DW; Li R
Virology; 2020 Jan; 540():75-87. PubMed ID: 31743858
[TBL] [Abstract][Full Text] [Related]
7. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 8 regulates caspase-1 expression to facilitate Epstein-Barr virus reactivation in response to B cell receptor stimulation and chemical induction.
Lv DW; Zhang K; Li R
PLoS Pathog; 2018 Jan; 14(1):e1006868. PubMed ID: 29357389
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein.
Morrison TE; Mauser A; Wong A; Ting JP; Kenney SC
Immunity; 2001 Nov; 15(5):787-99. PubMed ID: 11728340
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection.
Sato Y; Yaguchi M; Okuno Y; Ishimaru H; Sagou K; Ozaki S; Suzuki T; Inagaki T; Umeda M; Watanabe T; Fujimuro M; Murata T; Kimura H
Cell Commun Signal; 2022 Jun; 20(1):95. PubMed ID: 35729616
[TBL] [Abstract][Full Text] [Related]
11. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
Urin V; Shemesh M; Schreiber G
J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.
Geiger TR; Martin JM
J Virol; 2006 Dec; 80(23):11638-50. PubMed ID: 16987978
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.
Hergovits S; Mais C; Haan C; Costa-Pereira AP; Hermanns HM
J Cell Mol Med; 2017 Nov; 21(11):3087-3099. PubMed ID: 28560754
[TBL] [Abstract][Full Text] [Related]
15. IFIT3 inhibits Epstein-Barr virus reactivation via upregulating innate immunity.
Zhang W; Jiang M; Liao X; Li Y; Xin S; Yang L; Xin Y; Umar A; Lu J
J Med Virol; 2023 Nov; 95(11):e29237. PubMed ID: 37994186
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.
Sen N; Sung P; Panda A; Arvin AM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089701
[TBL] [Abstract][Full Text] [Related]
17. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
18. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
[TBL] [Abstract][Full Text] [Related]
19. Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.
Kim JY; Min YJ; Lee M-H; An YR; Ashktorab H; Smoot DT; Kwon SW; Lee SK
J Virol; 2024 Feb; 98(2):e0177623. PubMed ID: 38197630
[TBL] [Abstract][Full Text] [Related]
20. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]